Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -106.08 | -118.27 | -122.00 | -77.47 |
Depreciation/ Depletion | 5.82 | 5.83 | 3.56 | 3.52 |
Non- Cash Items | 4.58 | -1.09 | -4.66 | -6.22 |
Changesin Working Capital | 13.07 | 10.38 | -4.45 | -15.85 |
Cashfrom Operating Activities | -82.62 | -103.15 | -127.54 | -96.02 |
Other Investing Cash Flow Items Total | 61.59 | -257.75 | -2.46 | 62.15 |
Cashfrom Investing Activities | 61.59 | -260.65 | -22.23 | 55.84 |
Financing Cash Flow Items | -0.16 | -0.26 | -0.40 | -0.82 |
Issuance( Retirement)of Debt Net | -0.90 | -1.60 | -1.56 | -1.25 |
Cashfrom Financing Activities | -1.05 | 395.54 | 145.69 | 34.86 |
Net Changein Cash | -22.09 | 31.75 | -4.07 | -5.33 |
Cash Interest Paid | 0.16 | 0.26 | 0.40 | 0.82 |
Cash Taxes Paid | -6.18 | 1.10 | 0.52 | 1.15 |
Capital Expenditures | - | -2.89 | -19.77 | -6.30 |
Issuance( Retirement)of Stock Net | - | 397.40 | 147.64 | 36.92 |
Suven Life Sciences Dividend Suven Life Sciences Bonus Suven Life Sciences News Suven Life Sciences AGM Suven Life Sciences Rights Suven Life Sciences Splits Suven Life Sciences Board Meetings Suven Life Sciences Key Metrics Suven Life Sciences Shareholdings Suven Life Sciences Profit Loss Suven Life Sciences Balance Sheet Suven Life Sciences Q1 Results Suven Life Sciences Q2 Results Suven Life Sciences Q3 Results Suven Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks